{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:32:46Z","timestamp":1788067966100,"version":"build-2784847793"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["CRE Medicines and Ageing Small Project Grants schem"],"award-info":[{"award-number":["CRE Medicines and Ageing Small Project Grants schem"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40360-019-0333-7","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T13:15:03Z","timestamp":1567775703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adverse drug reactions due to opioid analgesic use in New South Wales, Australia: a spatial-temporal analysis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-2265","authenticated-orcid":false,"given":"Wei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanley","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"333_CR1","volume-title":"Post-market review of authority required PBS listings. Opioid Roundtable","author":"Department of Health","year":"2015","unstructured":"Department of Health. Post-market review of authority required PBS listings. Opioid Roundtable: 2015, May 27."},{"issue":"10028","key":"333_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644\u201356.","journal-title":"Lancet"},{"issue":"5","key":"333_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/bcp.12446","volume":"78","author":"B Blanch","year":"2014","unstructured":"Blanch B, Pearson S, Haber P. An overview of the patterns of prescription opioid use, costs and related harms in Australia. Br J Clin Pharmacol. 2014;78(5):1159\u201366.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"333_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bcp.12937","volume":"82","author":"E Karanges","year":"2016","unstructured":"Karanges E, Blanch B, Buckley N, et al. Twenty-five years of prescription opioid use in Australia: a whole of population analysis using pharmaceutical claims. Br J Clin Pharmacol. 2016;82(1):255\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"333_CR5","unstructured":"Britt H, Miller G, Henderson J. A decade of Australian general practice activity 2004-05 to 2013-14. General Practice Series 37. Sydney: Sydney University Press; 2014."},{"issue":"12","key":"333_CR6","doi-asserted-by":"publisher","first-page":"e80095","DOI":"10.1371\/journal.pone.0080095","volume":"8","author":"KD Roger","year":"2013","unstructured":"Roger KD, Kemp A, McLachlan AJ, Blyth F. Adverse selection? A multi-dimensional profile of people dispensed opioid analgesics for persistent non-cancer pain. PLoS One. 2013;8(12):e80095.","journal-title":"PLoS One"},{"key":"333_CR7","volume-title":"National opioid pharmacotherapy statistics 2014, AIHW bulletin 128","author":"Australian Institute of Health and Welfare","year":"2015","unstructured":"Australian Institute of Health and Welfare. National opioid pharmacotherapy statistics 2014, AIHW bulletin 128. Canberra: AIHW; 2015."},{"issue":"5","key":"333_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5694\/mja10.11450","volume":"195","author":"A Roxburgh","year":"2011","unstructured":"Roxburgh A, Bruno R, Larance B, et al. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195(5):280\u20134.","journal-title":"Med J Aust"},{"issue":"1","key":"333_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12024-014-9624-x","volume":"11","author":"J Pilgrim","year":"2015","unstructured":"Pilgrim J, Yafistham S, Gaya S, et al. An update on oxycodone: lessons for death investigators in Australia. Forensic Sci Med Pathol. 2015;11(1):3\u201312.","journal-title":"Forensic Sci Med Pathol"},{"issue":"2","key":"333_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ajim.20655","volume":"52","author":"BS Webster","year":"2009","unstructured":"Webster BS, Cifuentes M, Verma S, et al. Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: a multilevel analysis. Am J Ind Med. 2009;52(2):162\u201371.","journal-title":"Am J Ind Med"},{"issue":"6","key":"333_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/pds.1939","volume":"19","author":"JS Brownstein","year":"2010","unstructured":"Brownstein JS, Green TC, Cassidy TA, et al. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf. 2010;19(6):627\u201337.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"333_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40360-018-0219-0","volume":"19","author":"M Islam","year":"2018","unstructured":"Islam M, McRae I, Mazumdar S, et al. Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation. BMC Pharmacol Toxicol. 2018;19:30.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"10","key":"333_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jama.2018.0900","volume":"319","author":"L Dwyer-Lindgren","year":"2018","unstructured":"Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs R, et al. Trends and patterns of geographic variation in mortality from substance use disorders and intentional injuries among US counties, 1980-2014. JAMA. 2018;319(10):1013\u201323.","journal-title":"JAMA"},{"issue":"4","key":"333_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","volume":"162","author":"R Chou","year":"2015","unstructured":"Chou R, Turner J, Devine E, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162(4):276\u201386.","journal-title":"Ann Intern Med"},{"issue":"3","key":"333_CR15","first-page":"PCC.11m01326","volume":"14","author":"A Baldini","year":"2012","unstructured":"Baldini A, Von Korff M, Lin E. A review of potential adverse effects of long-term opioid therapy: a practitioner\u2019s guide. Prim Care Companion CNS Disord. 2012;14(3):PCC.11m01326.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"3","key":"333_CR16","first-page":"444","volume":"17","author":"Y Khodneva","year":"2016","unstructured":"Khodneva Y, Muntner P, Kertesz S, et al. Prescription opioid use and risk of coronary heart disease, stroke, and cardiovascular death among adults from a prospective cohort. Pain Med. 2016;17(3):444\u201355.","journal-title":"Pain Med"},{"issue":"22","key":"333_CR17","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1001\/archinternmed.2010.391","volume":"170","author":"D Solomon","year":"2010","unstructured":"Solomon D, Rassen J, Glynn R, et al. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010;170(22):1968\u201376.","journal-title":"Arch Intern Med"},{"issue":"22","key":"333_CR18","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1001\/archinternmed.2010.450","volume":"170","author":"D Solomon","year":"2010","unstructured":"Solomon D, Rassen J, Glynn R, et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010;170(22):1979\u201386.","journal-title":"Arch Intern Med"},{"issue":"3","key":"333_CR19","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1371\/journal.pmed.0020059","volume":"2","author":"M Kulldorff","year":"2005","unstructured":"Kulldorff M, Heffernan R, Hartman J, et al. A space-time permutation scan statistic for disease outbreak detection. PLoS Med. 2005;2(3):e59.","journal-title":"PLoS Med"},{"issue":"3","key":"333_CR20","doi-asserted-by":"publisher","first-page":"e33236","DOI":"10.1371\/journal.pone.0033236","volume":"7","author":"K Hakkarainen","year":"2012","unstructured":"Hakkarainen K, Hedna K, Petzold M, et al. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions \u2013 a meta-analysis. PLoS One. 2012;7(3):e33236.","journal-title":"PLoS One"},{"key":"333_CR21","volume-title":"International statistical classification of diseases and related health problems, 10th Revision, Australian modification (ICD-10-AM)","author":"National Centre for Classification in Health","year":"2006","unstructured":"National Centre for Classification in Health. International statistical classification of diseases and related health problems, 10th Revision, Australian modification (ICD-10-AM). 5th ed. Sydney: National Centre for Classification in Health; 2006.","edition":"5"},{"key":"333_CR22","volume-title":"Information Paper 2039.0: an introduction to socio-economic indexes for areas (SEIFA)","author":"Australian Bureau of Statistics (ABS)","year":"2006","unstructured":"Australian Bureau of Statistics (ABS). Information Paper 2039.0: an introduction to socio-economic indexes for areas (SEIFA). Canberra: ABS; 2006."},{"key":"333_CR23","volume-title":"Rural, regional and remote health: a guide to remoteness classifications","author":"Australian Institute of Health and Welfare (AIHW)","year":"2004","unstructured":"Australian Institute of Health and Welfare (AIHW). Rural, regional and remote health: a guide to remoteness classifications. Canberra: AIHW; 2004."},{"key":"333_CR24","volume-title":"Geographic access and spatial clustering of section 90 pharmacies \u22121990 to 2014: an exploratory analysis","author":"J Lange","year":"2016","unstructured":"Lange J, Franzon J. Geographic access and spatial clustering of section 90 pharmacies \u22121990 to 2014: an exploratory analysis. Canberra: Department of Health; 2016."},{"issue":"6","key":"333_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris C, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382.","journal-title":"Am J Epidemiol"},{"key":"333_CR26","volume-title":"SaTScan: software for the spatial and space-time scan statistics","author":"M Kulldorff","year":"2013","unstructured":"Kulldorff M, Rand K, Williams G. SaTScan: software for the spatial and space-time scan statistics. Bethesda: National Cancer Institute; 2013."},{"issue":"6","key":"333_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1080\/03610929708831995","volume":"26","author":"M Kulldorff","year":"1997","unstructured":"Kulldorff M. A spatial scan statistic. Commun Stat Theory Methods. 1997;26(6):1481\u201396.","journal-title":"Commun Stat Theory Methods"},{"issue":"1","key":"333_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/1467-985X.00186","volume":"164","author":"M Kulldorff","year":"2001","unstructured":"Kulldorff M. Prospective time periodic geographical disease surveillance using a scan statistic. J R Stat Soc A Stat Soc. 2001;164(1):61\u201372.","journal-title":"J R Stat Soc A Stat Soc"},{"key":"333_CR29","unstructured":"Agency for Healthcare Research and Quality. Trends in opioid-related hospitalizations. Available at: http:\/\/www.ahrq.gov\/news\/opioid-hospitalization-map.html . Accessed 12 Oct 2018."},{"issue":"1","key":"333_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imj.14134","volume":"49","author":"H Zhang","year":"2019","unstructured":"Zhang H, Du W, Gnjidic D, Chong S, Glasgow N. Trends in adverse drug reaction related hospitalisations over 13 years in New South Wales, Australia. Intern Med J. 2019;49(1):84\u201393.","journal-title":"Intern Med J"},{"key":"333_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/CEOR.S85213","volume":"7","author":"A Shei","year":"2015","unstructured":"Shei A, Hirst M, Kirson NY, et al. Estimating the health care burden of prescription opioid abuse in five European countries. Clinicoecon Outcomes Res. 2015;7:477\u201388.","journal-title":"Clinicoecon Outcomes Res"},{"key":"333_CR32","unstructured":"Australian Commission on Safety and Quality in Health Care. Australian Atlas of Healthcare Variation: Opioid medicines dispensing. Available at: https:\/\/acsqhc.maps.arcgis.com\/home\/index.html . Accessed 29 Mar 2019."},{"issue":"4","key":"333_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40258-014-0102-0","volume":"12","author":"JB Rice","year":"2014","unstructured":"Rice JB, Kirson NY, Shei A, et al. Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Appl Health Econ Health Policy. 2014;12(4):435\u201346.","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"333_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jamainternmed.2013.12711","volume":"174","author":"JA Gwira Baumblatt","year":"2014","unstructured":"Gwira Baumblatt JA, Wiedeman C, Dunn JR, et al. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174(5):796\u2013801.","journal-title":"JAMA Intern Med"},{"key":"333_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.drugalcdep.2014.02.701","volume":"138","author":"BN Cochran","year":"2014","unstructured":"Cochran BN, Flentje A, Heck NC, et al. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014;138:202\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"333_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0009-9236(03)00152-8","volume":"74","author":"M Cepeda","year":"2003","unstructured":"Cepeda M, Farrar J, Baumgarten M, et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003;74(2):102\u201312.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"333_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CIA.S1847","volume":"3","author":"D Chau","year":"2008","unstructured":"Chau D, Walker V, Pai L, et al. Opiates and elderly: use and side effects. Clin Interv Aging. 2008;3(2):273\u20138.","journal-title":"Clin Interv Aging"},{"key":"333_CR38","volume-title":"World report on ageing and health","author":"World Health Organizations (WHO)","year":"2015","unstructured":"World Health Organizations (WHO). World report on ageing and health. Geneva: WHO; 2015."},{"issue":"5","key":"333_CR39","first-page":"331","volume":"87","author":"R Pretorius","year":"2013","unstructured":"Pretorius R, Gataric G, Swedlund S, et al. Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013;87(5):331\u20136.","journal-title":"Am Fam Physician"},{"key":"333_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/jppr.1041","volume":"44","author":"R Elliott","year":"2014","unstructured":"Elliott R, Booth J. Problems with medicine use in older Australians: a review of recent literature. J Pharm Pract Res. 2014;44:258\u201371.","journal-title":"J Pharm Pract Res"},{"key":"333_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1017\/S0959259809990232","volume":"19","author":"S Mitchell","year":"2009","unstructured":"Mitchell S, Hilmer SN, McLachlan AJ. Clinical pharmacology of analgesics in old age and frailty. Rev Clin Gerontol. 2009;19:103\u201318.","journal-title":"Rev Clin Gerontol"},{"issue":"3","key":"333_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2125.2010.03847.x","volume":"71","author":"AJ McLachlan","year":"2011","unstructured":"McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesics in older people: impact of frailty and cognition. Br J Clin Pharmacol. 2011;71(3):351\u201364.","journal-title":"Br J Clin Pharmacol"},{"key":"333_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2015.01.027","volume":"149","author":"N West","year":"2015","unstructured":"West N, Severtson S, Green J, et al. Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend. 2015;149:117\u201321.","journal-title":"Drug Alcohol Depend"},{"key":"333_CR44","volume-title":"Trends in drug use and related harms in Australia, 2001 to 2013","author":"A Roxburgh","year":"2013","unstructured":"Roxburgh A, Ritter A, Slade T, et al. Trends in drug use and related harms in Australia, 2001 to 2013. National Drug and Alcohol Research Centre: Sydney; 2013."},{"key":"333_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s40266-013-0115-7","volume":"30","author":"S Gadzhanova","year":"2013","unstructured":"Gadzhanova S, Bell J, Roughead E. What analgesics do older people use prior to initiating oxycodone for non-cancer pain? A retrospective database study. Drugs Aging. 2013;30:921\u20136.","journal-title":"Drugs Aging"},{"issue":"2","key":"333_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.j.pain.0000460303.63948.8e","volume":"156","author":"G Campbell","year":"2015","unstructured":"Campbell G, Nielsen S, Bruno R, et al. The pain and opioids IN treatment (POINT) study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain. 2015;156(2):231\u201342.","journal-title":"Pain"},{"issue":"1","key":"333_CR47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5694\/j.1326-5377.1997.tb138760.x","volume":"167","author":"P Graziotti","year":"1997","unstructured":"Graziotti P, Goucke C. The use of oral opioids in patients with chronic non-cancer pain: management strategies. Med J Aust. 1997;167(1):30\u20134.","journal-title":"Med J Aust"},{"issue":"4","key":"333_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids. Pain Pract. 2008;8(4):287\u2013313.","journal-title":"Pain Pract"},{"issue":"2","key":"333_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo G, Fine P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113\u201330.","journal-title":"J Pain"},{"key":"333_CR50","doi-asserted-by":"crossref","unstructured":"Centre for Disease Control and Prevention. CDC Guideline for Prescribing Opioids for Chronic Pain. Available at: https:\/\/www.cdc.gov\/drugoverdose\/ prescribing \/guideline.html. Accessed 12 Oct 2018.","DOI":"10.1201\/9781315201108-117"},{"key":"333_CR51","first-page":"CD011056","volume":"5","author":"PJ Wiffen","year":"2014","unstructured":"Wiffen PJ, Derry S, Moore RA. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database Syst Rev. 2014;5:CD011056.","journal-title":"Cochrane Database Syst Rev"},{"key":"333_CR52","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7:CD012592.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"333_CR53","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamainternmed.2016.1251","volume":"176","author":"SC Abdel","year":"2016","unstructured":"Abdel SC, Maher CG, Williams KA, et al. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low Back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958\u201368.","journal-title":"JAMA Intern Med"},{"key":"333_CR54","first-page":"CD006605","volume":"1","author":"M Noble","year":"2010","unstructured":"Noble M, Treadwell J, Tregear S, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1:CD006605.","journal-title":"Cochrane Database Syst Rev"},{"key":"333_CR55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.36076\/ppj.2011\/14\/91","volume":"14","author":"L Manchikanti","year":"2011","unstructured":"Manchikanti L, Ailinani H, Koyyalagunta D, et al. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011;14:91\u2013121.","journal-title":"Pain Physician"},{"issue":"1","key":"333_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/er.2009-0009","volume":"31","author":"C Vuong","year":"2010","unstructured":"Vuong C, Van Uum SHM, O\u2019Dell LE, et al. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2010;31(1):98\u2013132.","journal-title":"Endocr Rev"},{"key":"333_CR57","volume-title":"Report of the NSW pain management taskforce","author":"NSW Ministry of Health","year":"2012","unstructured":"NSW Ministry of Health. Report of the NSW pain management taskforce. North Sydney: NSW Ministry of Health; 2012."},{"issue":"6","key":"333_CR58","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/bcp.13556","volume":"84","author":"S Lalic","year":"2018","unstructured":"Lalic S, Gisev N, Bell JS, et al. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia. Br J Clin Pharmacol. 2018;84(6):1267\u201378.","journal-title":"Br J Clin Pharmacol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-019-0333-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-019-0333-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-019-0333-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T19:04:03Z","timestamp":1664305443000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-019-0333-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/s40360-019-0333-7","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Australian National University Science & Medical Delegated Ethics Review Committee approved this study (#2016\/030), with the need for consent waived given the use of de-identifiable data for secondary analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}